Trump’s Medicaid Cuts Were Aimed at ‘Able-Bodied Adults.’ Hospitals Say Kids Will Be Hurt.

Republicans insist that President Donald Trump’s cuts to Medicaid were aimed at reducing fraud and getting more of its adult beneficiaries into jobs. But the side effects may include less care for sick kids. Some children’s hospitals collectively stand to lose billions of dollars in revenue once Trump’s wide-ranging tax and spending law, which Republicans…

Read More

RFK Jr. Said ‘Everybody Can Get’ a Covid Vaccine. Is That True?

“Everybody can get” the covid-19 vaccine. Robert F. Kennedy Jr. on Sept. 4 in a Senate Finance Committee hearing When health secretary Robert F. Kennedy Jr. testified before the Senate Finance Committee on Sept. 4, several senators criticized him for restricting the covid-19 shots after promising in November he wouldn’t “take away anybody’s vaccines.” “Did…

Read More

Are private health insurers evil?

Michael Cannon makes the convincing case that the answer is a resounding ‘no’. Those who say that private health insurance companies are evil entities that profit from denying health care to patients fail to appreciate that private health insurance companies are in fact a wondrous force for good.Outrageous? Not at all. Health insurance companies get…

Read More

Corewell Health Touts Success of Virtual Lifestyle Medicine Program with Nudj Health

Corewell Health is seeing positive results from its partnership with Nudj Health, a startup that delivers virtual lifestyle medicine programs. More than 3,600 Corewell patients have enrolled in Nudj’s programs since 2023 — and their reported improvements include weight loss, reduced depression and anxiety levels, better cholesterol and triglyceride levels, and increased daily exercise minutes….

Read More

Novartis’s $1.4B Tourmaline Acquisition Brings Heart Drug That Could Rival Novo Nordisk, CSL Meds

Novartis is getting Tourmaline Bio’s pacibekitug, a Phase 3-ready antibody drug in development for atherosclerotic cardiovascular disease (ASCVD). Tourmaline licensed pacibekitug from Pfizer, which remains eligible for milestone payments tied to the progress of the drug. The post Novartis’s $1.4B Tourmaline Acquisition Brings Heart Drug That Could Rival Novo Nordisk, CSL Meds appeared first on…

Read More